Literature DB >> 24014809

Ontogeny and control of the heart rate power spectrum in the last third of gestation in fetal sheep.

Miriam E Koome1, Laura Bennet, Lindsea C Booth, Joanne O Davidson, Guido Wassink, Alistair Jan Gunn.   

Abstract

Power spectral analysis of fetal heart rate variability has been proposed to provide a non-invasive estimate of autonomic balance. However, there are few systematic data before birth. We therefore examined developmental changes in the frequency power spectrum at very low (0-0.04 Hz), low (0.04-0.15 Hz) and high frequencies (0.15-0.4 Hz), as well as the ratio of low- to high-frequency power (LF/HF), in chronically catheterized, healthy fetal sheep at 0.6 (n = 8), 0.7 (n = 7) and 0.8 gestational age (ga; n = 11). In a second study, 0.8 ga fetuses received either atropine (4.8 mg bolus, then 4.8 mg h(-1) for 30 min, n = 6) or 6-hydroxydopamine (20 mg ml(-1) at 2.5 ml h(-1) for 3 h; n = 9). Data were analysed by sleep state, defined by low-voltage-high-frequency (LV) or high-voltage-low-frequency (HV) EEG. Total spectral power increased with gestational age (P < 0.05), while LF/HF decreased from 0.6 to 0.7 ga. At 0.8 ga, heart rate and LF/HF were significantly higher during HV than LV sleep (P < 0.05). Consistent with this, although total spectral power was not significantly greater during HV sleep, there was a significant interaction between sleep state and frequency band (P = 0.02). Both atropine (P = 0.05) and 6-hydroxydopamine (P < 0.05) were associated with an overall reduction in spectral power but no significant effect on the LF/HF ratio. This study does not support substantial, consistent differences between the frequencies of sympathetic and parasympathetic activity in late-gestation fetal sheep.

Entities:  

Mesh:

Year:  2013        PMID: 24014809     DOI: 10.1113/expphysiol.2013.074567

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  8 in total

1.  Analysis of fetal heart rate variability in frequency domain: methodical considerations.

Authors:  Daniela Casati; Martin G Frasch
Journal:  Exp Physiol       Date:  2014-02       Impact factor: 2.969

2.  Effect of maternal position on fetal behavioural state and heart rate variability in healthy late gestation pregnancy.

Authors:  Peter R Stone; Wendy Burgess; Jordan P R McIntyre; Alistair J Gunn; Christopher A Lear; Laura Bennet; Edwin A Mitchell; John M D Thompson
Journal:  J Physiol       Date:  2016-12-11       Impact factor: 5.182

3.  Use of radiotelemetry to assess perinatal cardiac function in the ovine fetus and newborn.

Authors:  A Antolic; C E Wood; M Keller-Wood
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-30       Impact factor: 3.619

4.  Sympathetic neural activation does not mediate heart rate variability during repeated brief umbilical cord occlusions in near-term fetal sheep.

Authors:  Christopher A Lear; Robert Galinsky; Guido Wassink; Clinton J Mitchell; Joanne O Davidson; Jennifer A Westgate; Laura Bennet; Alistair J Gunn
Journal:  J Physiol       Date:  2015-05-22       Impact factor: 5.182

5.  Fractal Analysis and Hurst Parameter for Intrapartum Fetal Heart Rate Variability Analysis: A Versatile Alternative to Frequency Bands and LF/HF Ratio.

Authors:  Muriel Doret; Jiří Spilka; Václav Chudáček; Paulo Gonçalves; Patrice Abry
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

6.  Altered autonomic control of heart rate variability in the chronically hypoxic fetus.

Authors:  C J Shaw; B J Allison; N Itani; K J Botting; Y Niu; C C Lees; D A Giussani
Journal:  J Physiol       Date:  2018-04-29       Impact factor: 5.182

Review 7.  Fetal movements as a predictor of health.

Authors:  Jonathan Lai; Niamh C Nowlan; Ravi Vaidyanathan; Caroline J Shaw; Christoph C Lees
Journal:  Acta Obstet Gynecol Scand       Date:  2016-09       Impact factor: 3.636

8.  Fetal heart rate variability is a biomarker of rapid but not progressive exacerbation of inflammation in preterm fetal sheep.

Authors:  Shoichi Magawa; Christopher A Lear; Michael J Beacom; Victoria J King; Michi Kasai; Robert Galinsky; Tomoaki Ikeda; Alistair J Gunn; Laura Bennet
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.